Conference Coverage

Ischemic mitral regurgitation: valve repair vs. replacement

Publish date: January 30, 2016

 

EXPERT ANALYSIS FROM THE CARDIOVASCULAR CONFERENCE AT SNOWMASS

References

Dr. Mack reported receiving research grants from Abbott Vascular, which is sponsoring the COAPT trial, as well as from Edwards Lifesciences.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Aortic valve replacement: Transcatheter soars past surgical
MDedge Cardiology
3D imaging tracks causes of post-TAVR aortic regurgitation
MDedge Cardiology
Immediate treatment yields best outcomes in NSTEMI MI
MDedge Cardiology
Post-repair MR may be worse than thought
MDedge Cardiology
Off-pump bypass may confer stroke benefit
MDedge Cardiology
Finding more transplant hearts but not more donors
MDedge Cardiology
FDA approves marketing of sutureless aortic valve
MDedge Cardiology
STS: Score stratifies risks for isolated tricuspid valve surgery patients
MDedge Cardiology
VIDEO: Shorter gap from heart attack to CABG shown safe
MDedge Cardiology
VIDEO: U.S. TAVR growth continues, mostly among octogenarians
MDedge Cardiology